434 filings
Page 8 of 22
8-K
5vv7yr7jlevpvgf5
3 Jun 10
Entry into a Material Definitive Agreement
12:00am
8-K
aq2k kucq
24 May 10
Other Events
12:00am
8-K
xe4qp lewb6u3yzwy
21 May 10
Salix Announces Issuance of U.S. Patent for Rifaximin
12:00am
8-K
rtw 8jx8zy6j0hggg6iy
10 May 10
Results of Operations and Financial Condition
12:00am
8-K
zovrc0 xmd
7 May 10
Other Events
12:00am
8-K
a33onmzrqg
5 May 10
Other Events
12:00am
8-K
jjwdr4
29 Apr 10
Conference Call and Webcast
12:00am
8-K
o5c32
23 Apr 10
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
pnoz 336qevq863kws
26 Mar 10
Fda Approves Xifaxan® 550 MG Tablets for Reduction In Risk of Overt Hepatic Encephalopathy (He) Recurrence
12:00am
8-K
3ssp1
9 Mar 10
4Q2009 and FY2009 Results
12:00am
8-K
j89vqyxj4r9m6f
24 Feb 10
Other Events
12:00am
8-K
fh2qghrxvq5d0 lls3hp
10 Dec 09
Regulation FD Disclosure
12:00am
8-K
3cruunzeelpy2zyfp
24 Nov 09
Other Events
12:00am
8-K
6pc0xwuwdm0rcoy9 7u
23 Nov 09
Completes Sale of 6.325 Million Shares of Common Stock
12:00am
8-K
h0kuiq
19 Nov 09
Announces Pricing of a Public Offering of Common Stock
12:00am
8-K
0yl7y
9 Nov 09
METOZOLV™ ODT Receives FDA Marketing Approval
12:00am
8-K
zm1n6eoyj
5 Nov 09
Other Events
12:00am
8-K
3fya5mlc0s29buyzlk80
27 Oct 09
Other Events
12:00am
8-K
is6x36
26 Oct 09
Conference Call and Webcast
12:00am
8-K
idnlvm
5 Oct 09
Entry into a Material Definitive Agreement
12:00am